IASLC WCLC 2016
December 4-7, 2016

Registration & Abstract Submission
Now Open

IASLC Lung Cancer News
Issue #2

The LCFA/IASLC Lori Monroe
Scholarship in Translational
Lung Cancer Research

2 lung cancer research grants - $200,000 over 2 years
Deadline: June 30, 2016

IASLC Foundation

 

 

 Donate Now

 

We are a global network of specialists working together to conquer lung and thoracic cancers worldwide.

LALCA 2016
August 25-27, 2016

Registration & Abstract Submission
Now Open

More Details

 

IASLC 2016 Chicago Meeting
September 22-24, 2016

Abstract Deadline: July 15, 2016

MORE DETAILS 

Featured Science and Communiqués

Adjuvant Chemotherapy Improves Overall Survival in Patients with Stage IB Non-Small Cell Lung Cancer

DENVER – The use of adjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in patients with tumor sizes ranging from 3.1 – 7 cm.

IASLC Consensus Statement on Optimizing Management of EGFR Mutation Positive NSCLC Patients

DENVER – The International Association for the Study of Lung Cancer (IASLC) created the 2016 consensus statement on optimizing management of epidermal growth factor receptor (EGFR) mutation positive (M+) non-small cell lung cancer (NSCLC) patients, published in the Journal of Thoracic Oncology (JTO), to discuss key pathologic, diagnostic, and therapeutic considerations. The statement also makes recommendations for clinical guidance and research priorities, such as optimal choice of EGFR tyrosine kinase inhibitors (TKIs), management of brain metastasis, role of re-biopsies, and use of circulating free DNA (cfDNA) for molecular studies.

Scientific Advances in Lung Cancer in 2015 Highlighted by IASLC

DENVER – Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging, and treatment in 2015, the International Association for the Study of Lung Cancer (IASLC) announces the inaugural publication of “Scientific Advances in Lung Cancer 2015” in the May 2016 issue of the IASLC’s Journal of Thoracic Oncology (JTO).

Features of the 2016 Asia Pacific Lung Cancer Conference (APLCC)

CHIANG MAI, THAILAND – The 2016 IASLC Asia Pacific Lung Cancer Conference (APLCC), held May 13-15, is organized under the aegis of International Association for the Study of Lung Cancer (IASLC), Thai Society of Clinical Oncology (TSCO), Chiang Mai Lung Cancer Group, Faculty of Medicine at the Chiang Mai University (CMU) and the local organizing committee of APLCC 2016.